Free Trial
→ Crypto’s crashing…but we’re still profiting (From Crypto Swap Profits) (Ad) Buy NRSNW Stock  Free NRSNW Stock Alerts

NeuroSense Therapeutics (NRSNW) SEC Filings & 10K Form

$0.26 +0.06 (+30.85%)
As of 04/17/2025 12:47 PM Eastern
Compare

Recent NeuroSense Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/11/2025
3:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
04/11/2025
3:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
04/07/2025
4:25 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
01/06/2025
9:40 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:47 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/23/2024
8:04 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
10:06 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
1:42 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
12/12/2024
4:08 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
12/04/2024
7:32 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
3:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
11/22/2024
3:30 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
10/31/2024
3:59 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
10/01/2024
5:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
09/30/2024
3:53 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
7:05 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)

Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.

See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro
06/27/2024
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/24/2024
8:20 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:42 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
4:24 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/17/2024
4:25 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/17/2024
4:22 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
6:14 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
05/20/2024
3:16 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form F-1/A
05/20/2024
8:02 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
8:02 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
9:21 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:01 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRSNW) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored